- R&I-1446
- June 2021
- 287
- PPT, PDF, WORD, EXCEL
- Healthcare & Life Sciences
address
1820 Avenue M, Brooklyn, NY, 11230, United States
mail address
sales@reportsandinsights.comContact no.
Molecular Diagnostics and NAT Market Overview
The report is titled ‘Molecular Diagnostics and NAT Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the Molecular Diagnostics and NAT market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The Molecular Diagnostics and NAT market is expected to grow at a significant rate in the near future.
Molecular Diagnostics and NAT Introduction
Molecular diagnostics can be understood as an assemblage of methods employed to examine biological markers in the proteome and genome—the single entity’s genetic code and how their cells articulate their genes as proteins—by implementing molecular biology to medical testing. The method is employed to diagnose and oversee disease, determine risks, and decide which remedial therapy will work best for individual patients.
Molecular diagnostics is witnessing high demand in the global markets for the diagnosis and medical treatment of various chronic diseases. Nucleic acid amplification test (NAT) is a kind of molecular diagnostics used for the determination of viruses and bacteria in any given specimen. Different varieties in the application that includes oligonucleotide microarrays, amplified gene detection technologies, gene sequencing, and amplification technologies, further broadens the scope of growth of the market.
Molecular Diagnostics and NAT Market Dynamics
One of the leading factors that is principally boosting the growth of the global molecular diagnostics and NAT market is the brisk penetration of molecular diagnostics in the healthcare sector and gaining enormous momentum in the global markets.
By the same token, the constantly rising prevalence of infectious diseases together with the growth in demand for advanced and modern molecular diagnostics techniques is also compelling the global manufacturers to make the ball rolling with the advancements in the market. Attributing to which, the global molecular diagnostics and NAT market is projected to climb higher in the years to come.
Also, in the past few decades, there has been extensive research & developments activities carried out in the medical and diagnostic imaging field that is further strengthening the growth of the global molecular diagnostics and NAT market.
Along with that, the leading manufacturers are also aiming their attention at improving the diagnostic and medical imaging field and making it cost-effective to gain more momentum in the global market which is also playing a positive rule in fueling the growth of the global molecular diagnostics and NAT market in the given timeframe. In conjunction with that, there have been plenty of investments from several governments all across the world, which is also anticipated to give numerous breakthroughs to the growth of the global molecular diagnostics and NAT market over the forecast period.
Molecular Diagnostics and NAT Market Segmentation
The global molecular diagnostics and NAT market is segmented on the basis of type, application and region. On the basis of the type, the molecular diagnostics and NAT market is segmented into Amplification Technologies, Amplified Gene Detection Technologies, DNA and Oligonucleotide Microarrays, Gene Sequencing. On the basis of application, the market is divided into ÐоѕріtаlÑ• and СlÑ–nÑ–ÑÑ•, RеѕеаrÑh ІnÑ•tÑ–tutеѕ, and DіаgnоѕtÑ–Ñ Ð¡ÐµntеrÑ•.
By Type
Amplification Technologies
Amplified Gene Detection Technologies
DNA and Oligonucleotide Microarrays
Gene Sequencing
By Application
ÐоѕріtаlÑ• and СlÑ–nÑ–ÑÑ•
RеѕеаrÑh ІnÑ•tÑ–tutеѕ
DіаgnоѕtÑ–Ñ Ð¡ÐµntеrÑ•
By Region
North America
Latin America
Asia Pacific
Europe
Middle East
Africa
Molecular Diagnostics and NAT Market Key Players
The global molecular diagnostics and NAT market is dominated by Roche, Abbott, BD, Biomerieux, Qiagen, Thermo Fisher Scientific, Agilent, GenMark, Siemens Healthcare, AutoGenomics, among others.
R&I Overview on Molecular Diagnostics and NAT Market Report
The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.
A research report on the molecular diagnostics and NAT market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
New product designs and launches
Current product compliance
Reimbursement
Concerns for use of Molecular Diagnostics and NAT
Advantages of Molecular Diagnostics and NAT
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to make informed decisions.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.
1. Global Molecular Diagnostics and NAT Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Molecular Diagnostics and NAT Market Overview
2.1. Introduction
2.1.1. Introduction
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Molecular Diagnostics and NAT Market Snapshot
2.4. Global Molecular Diagnostics and NAT Market Size And Forecast, 2020–2028
2.4.1. Introduction
2.4.2. Market Value Forecast And Annual Growth Rate (AGR) Comparison (2020–2028)
2.5. Global Molecular Diagnostics and NAT Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Porter’s Five Forces Model
2.7. SWOT Analysis
3. Molecular Diagnostics and NAT Assessment and Analysis
3.1. Molecular Diagnostics and NAT Impact Analysis
3.2. Actions to encourage use of Molecular Diagnostics and NAT
3.3. Molecular Diagnostics and NAT Promotional Strategy Recommendation
3.4. Road Map Analysis
3.5. GAP Analysis
3.6. Potential Analysis
4. Covid-19 Impact on Molecular Diagnostics and NAT Market
5. Global Molecular Diagnostics and NAT Market, By Type
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By Type
5.1.2. BPS Analysis, By Type
5.2. Market Revenue (US$Mn) and Forecast, By Type
5.2.1. Amplification Technologies
5.2.2. Amplified Gene Detection Technologies
5.2.3. DNA And Oligonucleotide Microarrays
5.2.4. Gene Sequencing
5.3. Global Molecular Diagnostics and NAT Market Attractiveness Index, By Type
6. Global Molecular Diagnostics and NAT Market, By Application
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By Application
6.1.2. BPS Analysis, By Application
6.2. Market Revenue (US$Mn) and Forecast, By Application
6.2.1. Hospitals and Clinics
6.2.2. RеѕеаrÑh ІnÑ•tÑ–tutеѕ
6.2.3. DіаgnоѕtÑ–Ñ Ð¡ÐµntеrÑ•
6.3. Global Molecular Diagnostics and NAT Market Attractiveness Index, By Application
7. Global Molecular Diagnostics and NAT Market, By Region
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Region
7.1.2. BPS Analysis, By Region
7.2. Market Revenue (US$Mn) and Forecast, By Region
7.2.1. North America
7.2.2. Latin America
7.2.3. Europe
7.2.4. Asia Pacific
7.2.5. Middle East
7.2.6. Africa
7.3. Global Molecular Diagnostics and NAT Market Attractiveness Index, By Region
8. North America Molecular Diagnostics and NAT Market Analysis and Forecast, 2020–2028
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market Revenue (US$Mn) and Forecast, By Country
8.2.1. U.S. Molecular Diagnostics and NAT Market
8.2.2. Canada Molecular Diagnostics and NAT Market
8.3. North America Molecular Diagnostics and NAT Market, By Type
8.3.1. Amplification Technologies
8.3.2. Amplified Gene Detection Technologies
8.3.3. DNA And Oligonucleotide Microarrays
8.3.4. Gene Sequencing
8.4. North America Molecular Diagnostics and NAT Market Revenue (US$Mn) and Forecast, By Application
8.4.1. Hospitals and Clinics
8.4.2. RеѕеаrÑh ІnÑ•tÑ–tutеѕ
8.4.3. DіаgnоѕtÑ–Ñ Ð¡ÐµntеrÑ•
8.5. North America Molecular Diagnostics and NAT Market Attractiveness Index
8.5.1. By Country
8.5.2. By Type
8.5.3. By Application
9. Latin America Molecular Diagnostics and NAT Market Analysis and Forecast, 2020–2028
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market (US$Mn) Forecast, By Country
9.2.1. Brazil Molecular Diagnostics and NAT Market
9.2.2. Mexico Molecular Diagnostics and NAT Market
9.2.3. Rest Of Latin America Molecular Diagnostics and NAT Market
9.3. Latin America Molecular Diagnostics and NAT Market, By Type
9.3.1. Amplification Technologies
9.3.2. Amplified Gene Detection Technologies
9.3.3. DNA And Oligonucleotide Microarrays
9.3.4. Gene Sequencing
9.4. Latin America Molecular Diagnostics and NAT Market Revenue (US$Mn) and Forecast, By Application
9.4.1. Hospitals and Clinics
9.4.2. RеѕеаrÑh ІnÑ•tÑ–tutеѕ
9.4.3. DіаgnоѕtÑ–Ñ Ð¡ÐµntеrÑ•
9.5. Latin America Molecular Diagnostics and NAT Market Attractiveness Index
9.5.1. By Country
9.5.2. By Type
9.5.3. By Application
10. Europe Molecular Diagnostics and NAT Market Analysis and Forecast, 2020–2028
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market (US$Mn) Forecast, By Country
10.2.1. U.K. Molecular Diagnostics and NAT Market
10.2.2. Germany Molecular Diagnostics and NAT Market
10.2.3. Italy Molecular Diagnostics and NAT Market
10.2.4. France Molecular Diagnostics and NAT Market
10.2.5. Spain Molecular Diagnostics and NAT Market
10.2.6. Russia Molecular Diagnostics and NAT Market
10.2.7. Rest Of Europe Molecular Diagnostics and NAT Market
10.3. Europe Molecular Diagnostics and NAT Market, By Type
10.3.1. Amplification Technologies
10.3.2. Amplified Gene Detection Technologies
10.3.3. DNA And Oligonucleotide Microarrays
10.3.4. Gene Sequencing
10.4. Europe Molecular Diagnostics and NAT Market Revenue (US$Mn) and Forecast, By Application
10.4.1. Hospitals and Clinics
10.4.2. RеѕеаrÑh ІnÑ•tÑ–tutеѕ
10.4.3. DіаgnоѕtÑ–Ñ Ð¡ÐµntеrÑ•
10.5. Europe Molecular Diagnostics and NAT Market Attractiveness Index
10.5.1. By Country
10.5.2. By Type
10.5.3. By Application
11. Asia Pacific Molecular Diagnostics and NAT Market Analysis and Forecast, 2020–2028
11.1. Introduction
11.1.1. Annual Growth Rate Comparison, By Country
11.1.2. BPS Analysis, By Country
11.2. Market (US$Mn) Forecast, By Country
11.2.1. China Molecular Diagnostics and NAT Market
11.2.2. India Molecular Diagnostics and NAT Market
11.2.3. Japan Molecular Diagnostics and NAT Market
11.2.4. Australia and New Zealand Molecular Diagnostics and NAT Market
11.2.5. South Korea Molecular Diagnostics and NAT Market
11.2.6. Rest of Asia Pacific Molecular Diagnostics and NAT Market
11.3. Asia Pacific Molecular Diagnostics and NAT Market, By Type
11.3.1. Amplification Technologies
11.3.2. Amplified Gene Detection Technologies
11.3.3. DNA And Oligonucleotide Microarrays
11.3.4. Gene Sequencing
11.4. Asia Pacific Molecular Diagnostics and NAT Market Revenue (US$Mn) and Forecast, By Application
11.4.1. Hospitals and Clinics
11.4.2. RеѕеаrÑh ІnÑ•tÑ–tutеѕ
11.4.3. DіаgnоѕtÑ–Ñ Ð¡ÐµntеrÑ•
11.5. Asia Pacific Molecular Diagnostics and NAT Market Attractiveness Index
11.5.1. By Country
11.5.2. By Type
11.5.3. By Application
12. Middle East Molecular Diagnostics and NAT Market Analysis and Forecast, 2020–2028
12.1. Introduction
12.1.1. Annual Growth Rate Comparison, By Country
12.1.2. BPS Analysis, By Country
12.2. Market (US$Mn) Forecast, By Country
12.2.1. GCC Countries Molecular Diagnostics and NAT Market
12.2.2. Israel Molecular Diagnostics and NAT Market
12.2.3. Rest Of Middle East Molecular Diagnostics and NAT Market
12.3. Middle East Molecular Diagnostics and NAT Market, By Type
12.3.1. Amplification Technologies
12.3.2. Amplified Gene Detection Technologies
12.3.3. DNA And Oligonucleotide Microarrays
12.3.4. Gene Sequencing
12.4. Middle East Molecular Diagnostics and NAT Market Revenue (US$Mn) and Forecast, By Application
12.4.1. Hospitals and Clinics
12.4.2. RеѕеаrÑh ІnÑ•tÑ–tutеѕ
12.4.3. DіаgnоѕtÑ–Ñ Ð¡ÐµntеrÑ•
12.5. Middle East Molecular Diagnostics and NAT Market Attractiveness Index
12.5.1. By Country
12.5.2. By Type
12.5.3. By Application
13. Africa Molecular Diagnostics and NAT Market Analysis and Forecast, 2020–2028
13.1. Introduction
13.1.1. Annual Growth Rate Comparison, By Country
13.1.2. BPS Analysis, By Country
13.2. Market (US$Mn) Forecast, By Country
13.2.1. South Africa Countries Molecular Diagnostics and NAT Market
13.2.2. Egypt Molecular Diagnostics and NAT Market
13.2.3. North Africa Molecular Diagnostics and NAT Market
13.2.4. Rest of Africa Molecular Diagnostics and NAT Market
13.3. Africa Molecular Diagnostics and NAT Market, By Type
13.3.1. Amplification Technologies
13.3.2. Amplified Gene Detection Technologies
13.3.3. DNA And Oligonucleotide Microarrays
13.3.4. Gene Sequencing
13.4. Africa Molecular Diagnostics and NAT Market Revenue (US$Mn) and Forecast, By Application
13.4.1. Hospitals and Clinics
13.4.2. RеѕеаrÑh ІnÑ•tÑ–tutеѕ
13.4.3. DіаgnоѕtÑ–Ñ Ð¡ÐµntеrÑ•
13.5. Africa Molecular Diagnostics and NAT Market Attractiveness Index
13.5.1. By Country
13.5.2. By Type
13.5.3. By Application
14. Competitive Landscape
14.1. Competitive Dashboard
14.2. Company Profiles
14.2.1. Roche
14.2.1.1. Company Overview
14.2.1.2. Financial Overview
14.2.1.3. Key Developments
14.2.1.4. Strategies
14.2.1.5. Product Analysis
14.2.2. Abbott
14.2.3. BD
14.2.4. Biomerieux
14.2.5. Qiagen
14.2.6. Thermo Fisher Scientific
14.2.7. Agilent
14.2.8. GenMark
14.2.9. Siemens Healthcare
14.2.10. AutoGenomics
15. Acronyms